Oka, The Carbon Insurance Company™ Recognized as ESGFinTech100 Leader
Compiled by specialist research firm FinTech Global, the prestigious list showcases leading providers harnessing technology to solve a significant industry problem or accelerate ESG initiatives. This year, the expert judging panel selected 100 companies from over 500 contenders. Oka's mission — to ensure every carbon credit is insured — resonated with the panel at a critical juncture for the voluntary carbon market (VCM).
"The ESGFinTech100 roster helps senior management to identify the ESG tech companies that are leading the pack. The detailed company profiles provide insights into how solutions work, the problems they solve, operational regions and much more. This is an essential guide for any firm committed to meet net zero targets."
Oka is dedicated to de-risking the VCM for buyers and sellers of carbon credits. Its first-of-its-kind carbon insurance solution provides buyers with financial compensation in the event of unforeseeable and unavoidable post-issuance risks, including reversal and invalidation. Protected by Oka, one credit purchased represents one metric ton of carbon removed. By upholding accounting integrity in the unregulated and unpredictable VCM, Oka instills confidence in and drives capital towards climate investments.
About Oka, The Carbon Insurance Company™
Follow Oka, The Carbon Insurance Company™
LinkedIn
Media Contact
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/oka-the-carbon-insurance-company-recognized-as-esgfintech100-leader-301972759.html
SOURCE Oka, The Carbon Insurance Company
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GAC Exports 223,000 Units in Jan-Oct, Setting a New Record! Steadily Advancing High-Quality Globalization
- FF EAI Robotics Ecosystem Announces Strategic Partnership with California Science and Technology University and Boston International Business School to Advance Robotics Education, Talent Development,
- Ivonescimab Receives NMPA Priority Review for First-Line Biliary Tract Cancer
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share